{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:47:18Z","timestamp":1768538838958,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T00:00:00Z","timestamp":1255392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s00228-009-0740-6","type":"journal-article","created":{"date-parts":[[2009,10,12]],"date-time":"2009-10-12T12:54:11Z","timestamp":1255352051000},"page":"153-158","source":"Crossref","is-referenced-by-count":18,"title":["Is cyclosporine A transport inhibited by pravastatin via multidrug resistant protein 2?"],"prefix":"10.1007","volume":"66","author":[{"given":"Ryuji","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Nishide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Kozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Urashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Ijiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,13]]},"reference":[{"key":"740_CR1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1023\/A:1023481418576","volume":"20","author":"YY Chiu","year":"2003","unstructured":"Chiu YY, Higaki K, Neudeck BL, Barnett JL, Welage LS, Amidon GL (2003) Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells. Pharm Res 20:749\u2013756","journal-title":"Pharm Res"},{"key":"740_CR2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1211\/0022357021778493","volume":"54","author":"T Sakaeda","year":"2002","unstructured":"Sakaeda T, Takara K, Kakumoto M, Ohmoto N, Nakamura T, Iwaki K, Tanigawara Y, Okumura K (2002) Simvastatin and lovastatin, but not pravastatin, interact with MDR1. J Pharm Pharmacol 54:419\u2013423","journal-title":"J Pharm Pharmacol"},{"key":"740_CR3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/01.ATV.0000254855.24394.f9","volume":"27","author":"E Yamamoto","year":"2007","unstructured":"Yamamoto E, Yamashita T, Tanaka T, Kataoka K, Tokutomi Y, Lai ZF, Dong YF, Matsuba S, Ogawa H, Kim-Mitsuyama S (2007) Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects. Arterioscler Thromb Vasc Biol 27:556\u2013563","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"740_CR4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00296-006-0270-9","volume":"27","author":"T Yamagata","year":"2007","unstructured":"Yamagata T, Kinoshita K, Nozaki Y, Sugiyama M, Ikoma S, Funauchi M (2007) Effects of pravastatin in murine collagen-induced arthritis. Rheumatol Int 27:631\u2013639","journal-title":"Rheumatol Int"},{"key":"740_CR5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.103.051300","volume":"306","author":"D Kobayashi","year":"2003","unstructured":"Kobayashi D, Nozawa T, Iwaki K, Nezu J, Tsuji A, Tamai I (2003) Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther 306:703\u2013708","journal-title":"J Pharmacol Exp Ther"},{"key":"740_CR6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/jpet.102.041921","volume":"304","author":"Y Shitara","year":"2003","unstructured":"Shitara Y, Itoh T, Sato H, AP LI, Sugiyama Y (2003) Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A. J Pharmacol Exp Ther 304:610\u2013616","journal-title":"J Pharmacol Exp Ther"},{"key":"740_CR7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0090-9556(24)15273-7","volume":"27","author":"W Jacobsen","year":"1999","unstructured":"Jacobsen W, Kirchner G, Hallensleben K, Mancinelli L, Deters M, Hackbarth I, Benet LZ, Sewing KF, Christians U (1999) Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver. Drug Metab Dispos 27:173\u2013179","journal-title":"Drug Metab Dispos"},{"key":"740_CR8","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1592\/phco.26.11.1601","volume":"26","author":"CW Holtzman","year":"2006","unstructured":"Holtzman CW, Wiggins BS, Spinler SA (2006) Role of P-glycoprotein in statin drug interactions. Pharmacotherapy 26:1601\u20131607","journal-title":"Pharmacotherapy"},{"key":"740_CR9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0090-9556(25)07353-2","volume":"24","author":"LS Gan","year":"1996","unstructured":"Gan LS, Moseley MA, Khosla B, Augustijns PF, Bradshaw TP, Hendren RW, Thakker DR (1996) CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells. Drug Metab Dispos 24:344\u2013349","journal-title":"Drug Metab Dispos"},{"key":"740_CR10","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.bcp.2006.07.020","volume":"72","author":"M Jin","year":"2006","unstructured":"Jin M, Shimada T, Yokogawa K, Nomura M, Ishizaki J, Piao Y, Kato Y, Tsuji A, Miyamoto K (2006) Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin A absorption, and effect of dexamethasone in small intestine of mice. Biochem Pharmacol 72:1042\u20131050","journal-title":"Biochem Pharmacol"},{"key":"740_CR11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1124\/jpet.105.085589","volume":"314","author":"S Matsushima","year":"2005","unstructured":"Matsushima S, Maeda K, Kondo C, Hirano M, Sasaki M, Suzuki H, Sugiyama Y (2005) Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)\/multidrug resistance-associated protein 2, OATP1B1\/multidrug resistance 1, and OATP1B1\/breast cancer resistance protein. J Pharmacol Exp Ther 314:1059\u20131067","journal-title":"J Pharmacol Exp Ther"},{"key":"740_CR12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.hepres.2005.08.013","volume":"34","author":"M Akashi","year":"2006","unstructured":"Akashi M, Tanaka A, Takikaw H (2006) Effect of cyclosporin A on the biliary excretion of cholephilic compounds in rats. Hepatol Res 34:193\u2013198","journal-title":"Hepatol Res"},{"key":"740_CR13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-3565(24)29314-9","volume":"299","author":"J Taipalensuu","year":"2001","unstructured":"Taipalensuu J, Tornblom H, Lindberg G, Einarsson C, Sjoqvist F, Melhus H, Garberg P, Sjostrom B, Lundgren B, Artursson P (2001) Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 299:164\u2013170","journal-title":"J Pharmacol Exp Ther"},{"key":"740_CR14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejps.2006.03.003","volume":"28","author":"A Seithel","year":"2006","unstructured":"Seithel A, Karlsson J, Hilgendorf C, Bjorquist A, Ungell AL (2006) Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells. Eur J Pharm Sci 28:291\u2013299","journal-title":"Eur J Pharm Sci"},{"key":"740_CR15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0024-3205(96)00631-5","volume":"60","author":"T Fujita","year":"1997","unstructured":"Fujita T, Yamada H, Fukuzumi M, Nishimaki A, Yamamoto A, Muranishi S (1997) Calcein is excreted from the intestinal mucosal cell membrane by the active transport system. Life Sci 60:307\u2013313","journal-title":"Life Sci"},{"key":"740_CR16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1124\/jpet.104.068775","volume":"311","author":"HM Prime-Chapman","year":"2004","unstructured":"Prime-Chapman HM, Fearn RA, Cooper AE, Moore V, Hirst BH (2004) Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells. J Pharmacol Exp Ther 311:476\u2013484","journal-title":"J Pharmacol Exp Ther"},{"key":"740_CR17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1432-1033.1992.tb17291.x","volume":"209","author":"T Koga","year":"1992","unstructured":"Koga T, Fukuda K, Shimada Y, Fukami M, Koike H, Tsujita Y (1992) Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. The relationship between inhibition of de novo sterol synthesis and active drug concentrations in the liver, spleen and testis in rat. Eur J Biochem 209:315\u2013319","journal-title":"Eur J Biochem"},{"key":"740_CR18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2133\/dmpk.17.23","volume":"17","author":"M Horikawa","year":"2002","unstructured":"Horikawa M, Kato Y, Tyson CA, Sugiyama Y (2002) The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites. Drug Metabol Pharmacokin 17:23\u201333","journal-title":"Drug Metabol Pharmacokin"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-009-0740-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-009-0740-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-009-0740-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T18:12:44Z","timestamp":1739383964000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-009-0740-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,13]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["740"],"URL":"https:\/\/doi.org\/10.1007\/s00228-009-0740-6","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,13]]}}}